Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Keady
Evaluation of the Cost Saving Potential of Introducing an Etanercept Biosimilar (Benepali®) for the Treatment of All Licensed Adult Etanercept Indications in the UK
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
GP2015: An Etanercept Biosimilar
BioDrugs
Medicine
Biotechnology
Pharmacology
Observational Study of Inflammatory Arthritis Treatment by Etanercept Originator Switched to an Etanercept Biosimilar
Reumatologia
Rheumatology
Allergy
Immunology
SAT0199 Switch From Innovator Etanercept to Biosimilar Etanercept in Inflammatory Rheumatic Diseases: The Experience of Cochin University Hospital Paris-France.
Real-World Evidence on Etanercept Biosimilar SB4 in Etanercept-Naïve or Switching Patients: A Systematic Review
Rheumatology and Therapy
547 Effectiveness of Etanercept in the Treatment of Toxic Epidermal Necrolysis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Switch From Reference Etanercept to SDZ ETN, an Etanercept Biosimilar, Does Not Impact Efficacy, Safety, and Immunogenicity of Etanercept in Patients With Moderate-To-Severe Rheumatoid Arthritis: 48-Week Results From the Phase III, Randomized, Double-Blind EQUIRA Study
Arthritis Research & Therapy
Meta-Analysis for Efficacy of Etanercept for Treatment of Psoriatic Arthritis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pss29 - Secukinumab Versus Etanercept for the Treatment of Psoriasis: A 52-Week Cost Per Responder Analysis From the Portuguese Payer Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Meta-Analysis of Efficacy of Etanercept for Treatment of Psoriatic Arthritis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
